COVID-19 vaccine Johnson & Johnson results in 85% of intensive care cases in one dose: PPTVHD36

Johnson & Johnson (JNJ) today announced results of Phase III clinical trials involving 43,783 people, 468 of whom were infected from various countries including the United States and Africa.

Thai people survey results with the COVID-19 vaccine

The results of the experiment showed that The vaccine was effective on average in 66% of moderate and critically ill cases. But the highest efficiency at 85% in case of severe illness With only 1 needle injection different from Pfizer-Biotech and Moderna vaccines, announced to be approximately 95% effective in 2 doses.

However, such experiments are not yet complete. The effect of protection in mid- and critical-term cases was 72% in the US and 66% in Latin America and just 57% in South Africa, where 95% of the COVID-19 mutated B.351 was found.

“The results of the COVID-19 vaccination A single dose shows hope and the potential to significantly reduce the severity of severe disease by providing an effective and well-tolerated vaccine with a single vaccination as a key component. Of the global public health response, ”said Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer, Johnson & Johnson

Johnson & Johnson, however, is in the final stages of trials in South Africa. Which, if passed safety trials The company will apply for emergency use approval with the US Food and Drug Administration. And will begin to process vaccine applications in other countries

“Johnson & Johnson” temporarily suspended COVID-19 vaccine test.

Most of these trials, meanwhile, have been performed in the United States and before new species emerge. That means everything is racing against time to vaccinate as many people as possible and as quickly as possible to prevent the spread of the virus.

Assoc. Prof. Teeraworathanarat, Faculty of Medicine Chulalongkorn University Has posted a message through Facebook “Thira Woratanarat” about this matter. The good thing about Johnson & Johnson vaccines is that it’s a single dose. And the storage of vaccines can be stored in a normal refrigerator. Unlike mRNA vaccines that must be stored at very cold temperatures, this can be a practical problem in countries without adequate cold chain systems.

Johnson & Johnson is expected to apply for approval to the relevant authorities in February. In this regard, considering the use of vaccines to prevent various diseases, the principles of deciding whether to inject anything or not. Need to consider the necessity Detailed information pertaining to that vaccine study Properties of prevention, injection method, number of times, time to injections Including any side effects or adverse reactions that may occur.

People should inquire about medical personnel thoroughly. And need to tell in detail about the underlying disease that you have And a history of drug allergies, food allergies or various allergic reactions In the past that used to be Will help each other be careful And make the right decisions You should wait at least 30 minutes after vaccination.

We must strictly protect ourselves and our family members. Do not let the infection be with love to everyone.

Compile and summarize information from johnson-johnson / Reuters

AFP figure

– .